Levetiracetam (Compound)

Synonyms:Levetiracetam, 102767-28-2, Keppra, (S)-2-(2-Oxopyrrolidin-1-yl)butanamide, Keppra XR, (2S)-2-(2-oxopyrrolidin-1-yl)butanamide, ucb L059, UCB-L 059, Levetiracetamum, Spritam, UCB-L059, (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, SIB-S1, (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, UNII-44YRR34555, MFCD03265610, UCB-22059, Levetiracetamum [INN-Latin], 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-, CHEBI:6437, Levetiracetam In Sodium Chloride, UCB 22059, 44YRR34555, Levroxa, (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, matever, Leviteracetam, Levipil, Torleva, Elepsia XR, (S)-Levetiracetam, SMR000466303, Keppra (TN), Levesam 500, Etiracetam levo-isomer, SR-01000759400, Levetiracetame, E Keppra, HSDB 7528, N03AX14, Levetiracetam [USAN:USP:INN:BAN], E keppra (TN), Levetiracetam solution, Levetiracetam- Bio-X, (S)-2-(2-Oxo-1-pyrrolidinyl)butyramide, L-059, 2(S)-(2-OXOPYRROLIDIN-1-YL)BUTYRAMIDE, CHEMBL1286, 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-, MLS000759403, MLS001424069, MLS006010215, BIDD:GT0242, SCHEMBL118843, GTPL6826, Levetiracetam (JAN/USP/INN), DTXSID9023207, AGB-101, Levetiracetam, >=98% (HPLC), Levetiracetam, analytical standard, HMS2051D07, HMS2089L20, HMS2235I18, HMS3262H11, HMS3713P16, HMS3884O11, Pharmakon1600-01502265, ACT02712, ALBB-027275, BCP11856, HY-B0106, ZINC1547851, Tox21_500835, BDBM50422542, NSC760119, s1356, STL388027, Levetiracetam 1.0 mg/ml in Methanol, AKOS015841981, AC-1479, CCG-100928, CS-1854, DB01202, KS-1176, LP00835, LS41261, MCULE-5120797917, NC00178, NSC 760119, NSC-760119, SDCCGSBI-0633760.P001, (2S)-(2-Oxopyrrolidin-1-yl)butyramide, NCGC00186028-01, NCGC00186028-13, NCGC00261520-01, (S)-2-(2-oxopyrrolidin-1-yl)butyramide, BL164623, (s)-2-(2-oxopyrrolidin-1-yl) butyramide, AB0012613, AM20070676

Pubchem:PUBCHEM:5284583

Id:5284583

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Levetiracetam's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Levetiracetam.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Levetiracetam.

Results found

Linked to

	Label	Description
	BRD-K49404994-001-09-1 Substance (Entity type)	A Substance
	levetiracetam (d48e87c3-099e-40da-b8cd-72611b15813a) Collection (Entity type)	Metadatata for levetiracetam
	DCSTRUCT ID 01563 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01563; PubChem_CID:5284583, FILE=drugcentral_drug_01563.json)
	levetiracetam negatively regulates S100A7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam in similarity relationship with Linsidomine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam positively regulates HMGCS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam in similarity relationship with Rivaroxaban Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam positively regulates RGS5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam negatively regulates PTX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levetiracetam positively regulates ADGRA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS